Table of contents
Volume 89, Issue 12
Published online 12 December 2003 (2165-2370)
Minireviews |
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letter to the Editor |
Indices
Review
Stamping out cancer FREE
U Sanyal
Br J Cancer 89: 2165-2171; doi:10.1038/sj.bjc.6601486
Minireviews
Applications of array technology: identification of molecular targets in bladder cancer FREE
M Sánchez-Carbayo and C Cordon-Cardo
Br J Cancer 89: 2172-2177; doi:10.1038/sj.bjc.6601406
Progress in treatment of small-cell lung cancer: role of CPT-11 FREE
N Saijo
Br J Cancer 89: 2178-2183; doi:10.1038/sj.bjc.6601456
Clinical
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy FREE
S Y El Sharouni, H B Kal and J J Battermann
Br J Cancer 89: 2184-2189; doi:10.1038/sj.bjc.6601418
Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study FREE
H Anderson, J M Addington-Hall, M D Peake, J McKendrik, K Keane and N Thatcher
Br J Cancer 89: 2190-2196; doi:10.1038/sj.bjc.6601420
Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects FREE
F Khan, J Everard, S Ahmed, R E Coleman, M Aitken and B W Hancock
Br J Cancer 89: 2197-2201; doi:10.1038/sj.bjc.6601422
Subjective quality of life and sexual functioning after germ-cell tumour therapy FREE
M J Fegg, A Gerl, T C Vollmer, U Gruber, C Jost, S Meiler and W Hiddemann
Br J Cancer 89: 2202-2206; doi:10.1038/sj.bjc.6601421
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer FREE
W Koizumi, S Tanabe, K Saigenji, A Ohtsu, N Boku, F Nagashima, K Shirao, Y Matsumura and M Gotoh
Br J Cancer 89: 2207-2212; doi:10.1038/sj.bjc.6601413
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial FREE
A Ravaud, N Trufflandier, J M Ferrière, M Debled, J Palussière, L Cany, R Gaston, S Mathoulin-Pélissier and B N Bui
Br J Cancer 89: 2213-2218; doi:10.1038/sj.bjc.6601419
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice FREE
C G Koedoot, R J de Haan, A M Stiggelbout, P F M Stalmeier, A de Graeff, P J M Bakker and J C J M de Haes
Br J Cancer 89: 2219-2226; doi:10.1038/sj.bjc.6601445
A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer FREE
F Wu, Z-B Wang, Y-De Cao, W-Z Chen, J Bai, J-Z Zou and H Zhu
Br J Cancer 89: 2227-2233; doi:10.1038/sj.bjc.6601411
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc
RI 
anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer FREE
R Repp, H H van Ojik, T Valerius, G Groenewegen, G Wieland, C Oetzel, B Stockmeyer, W Becker, M Eisenhut, H Steininger, Y M Deo, G H Blijham, J R Kalden, J G J van de Winkel and M Gramatzki
Br J Cancer 89: 2234-2243; doi:10.1038/sj.bjc.6601367
Molecular and Cellular Pathology
Survivin expression in oral squamous cell carcinoma FREE
L Lo Muzio, G Pannone, S Staibano, M D Mignogna, C Rubini, M A Mariggiò, M Procaccini, F Ferrari, G De Rosa and D C Altieri
Br J Cancer 89: 2244-2248; doi:10.1038/sj.bjc.6601402
TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva FREE
K J Rolfe, A B MacLean, J C Crow, E Benjamin, W M N Reid and C W Perrett
Br J Cancer 89: 2249-2253; doi:10.1038/sj.bjc.6601444
The embedded tumour: host physiology is important for the evaluation of tumour growth FREE
I M M van Leeuwen, C Zonneveld and S A L M Kooijman
Br J Cancer 89: 2254-2263; doi:10.1038/sj.bjc.6601394
Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation FREE
S R McKeown, T Robson, M E Price, E T S Ho, D G Hirst and V J McKelvey-Martin
Br J Cancer 89: 2264-2270; doi:10.1038/sj.bjc.6601426
Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity FREE
M A L Moneef, B T Sherwood, K J Bowman, R C Kockelbergh, R P Symonds, W P Steward, J K Mellon and G D D Jones
Br J Cancer 89: 2271-2276; doi:10.1038/sj.bjc.6601333
Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells FREE
A L Dunne, M E Price, C Mothersill, S R McKeown, T Robson and D G Hirst
Br J Cancer 89: 2277-2283; doi:10.1038/sj.bjc.6601427
Genetics and Genomics
Gene expression array profile of human osteosarcoma FREE
P Leonard, T Sharp, S Henderson, D Hewitt, J Pringle, A Sandison, A Goodship, J Whelan and C Boshoff
Br J Cancer 89: 2284-2288; doi:10.1038/sj.bjc.6601389
Allelotype of 28 human breast cancer cell lines and xenografts FREE
I C Harkes, F Elstrodt, W N M Dinjens, M Molier, J G M Klijn, E M J J Berns and M Schutte
Br J Cancer 89: 2289-2292; doi:10.1038/sj.bjc.6601448
C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro FREE
T Kusakari, M Kariya, M Mandai, Y Tsuruta, A A Hamid, K Fukuhara, K Nanbu, K Takakura and S Fujii
Br J Cancer 89: 2293-2298; doi:10.1038/sj.bjc.6601423
Experimental Therapeutics
Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C FREE
P A Whitehouse, S J Mercer, L A Knight, F Di Nicolantonio, A O'Callaghan and I A Cree on behalf of the Portsmouth Upper GI and Colorectal Cancer Multidisciplinary Teams
Br J Cancer 89: 2299-2304; doi:10.1038/sj.bjc.6601403
In vitro interaction between Ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects FREE
C Simoens, A E C Korst, C M J De Pooter, H A J Lambrechts, G G O Pattyn, G T Faircloth, F Lardon and J B Vermorken
Br J Cancer 89: 2305-2311; doi:10.1038/sj.bjc.6601431
Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapy FREE
H Atkins, B R Davies, J A Kirby and J D Kelly
Br J Cancer 89: 2312-2319; doi:10.1038/sj.bjc.6601474
Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model FREE
F Borle, A Radu, C Fontolliet, H van den Bergh, P Monnier and G Wagnières
Br J Cancer 89: 2320-2326; doi:10.1038/sj.bjc.6601428
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice FREE
P Leuraud, L Taillandier, L Aguirre-Cruz, J Medioni, E Crinière, Y Marie, A M Dutrillaux, M Kujas, A Duprez, J-Y Delattre, M-F Poupon and M Sanson
Br J Cancer 89: 2327-2332; doi:10.1038/sj.bjc.6601466
Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment FREE
D K Kelleher, O Thews, A Scherz, Y Salomon and P Vaupel
Br J Cancer 89: 2333-2339; doi:10.1038/sj.bjc.6601457
Letter to the Editor
Integrin-linked kinase (ILK) expression in human colon cancer FREE
V Bravou, G Klironomos, E Papadaki, D Stefanou and J Varakis
Br J Cancer 89: 2340-2341; doi:10.1038/sj.bjc.6601482
Indices
Author Index for Volume 88 FREE
Br J Cancer 89: 2342-2349; doi:10.1038/sj.bjc.6601553
Keyword Index for Volume 88 FREE
Br J Cancer 89: 2350-2354; doi:10.1038/sj.bjc.6601555
Author Index for Volume 89 FREE
Br J Cancer 89: 2355-2364; doi:10.1038/sj.bjc.6601554
Keyword Index for Volume 89 FREE
Br J Cancer 89: 2365-2370; doi:10.1038/sj.bjc.6601556
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
